Olympus Corporation

Equities

7733

JP3201200007

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange Other stock markets 11:30:00 17/07/2024 am IST			5-day change	1st Jan Change
2,682 ^JPY	+2.29%		+0.04%	+31.46%

15/07	Olympus Group Completes Sale of Orthopedic Business to Polaris Capital	MT
12/07	Polaris Capital Group Co., Ltd. acquired Olympus Terumo Biomaterials Corporation and FH Ortho SAS from Olympus Corporation.	CI

Tranche Update on Olympus Corporation's Equity Buyback Plan announced on November 24, 2017.

January 10, 2018 at 12:00 pm IST

From November 24, 2017 to December 31, 2017, the company has repurchased 286,100 shares, representing 0.08% for ¥1,212.27 million. With this, the company has completed the repurchase of 286,100 shares, representing 0.08% for ¥1,212.27 million under the buyback announced on November 24, 2017.

Latest news about Olympus Corporation

Olympus Group Completes Sale of Orthopedic Business to Polaris Capital	15/07	MT
Polaris Capital Group Co., Ltd. acquired Olympus Terumo Biomaterials Corporation and FH Ortho SAS from Olympus Corporation.	12/07	CI
Tranche Update on Olympus Corporation's Equity Buyback Plan announced on May 10, 2024.	01/07	CI
Fujifilm once struggled to sell cameras. Now, it can't keep up with demand	28/06	RE
Olympus Corporation and HCL Technologies Limited Expand Engineering and R&D Partnership	12/06	CI
Olympus Completes Disposal of Treasury Shares for Stock Compensation	10/06	MT
Jefferies Adjusts Olympus’ Price Target to 3,100 Yen From 2,500 Yen, Keeps at Buy	10/06	MT
Olympus Skips Buyback in May	05/06	MT
Olympus Enters into Put Option Agreement for Orthopedic Business Transfer	27/05	MT
Olympus' Attributable Profit Soars 69.1% in Fiscal 2024	13/05	MT
Japanese shares fall ahead of earnings reports; rising yields weigh	13/05	RE
Transcript : Olympus Corporation, 2024 Earnings Call, May 10, 2024	10/05
Olympus Corporation announces an Equity Buyback for 60,000,000 shares, representing 5.15% for ¥100,000 million.	10/05	CI
Olympus Corporation authorizes a Buyback Plan.	10/05	CI
Olympus to Return Land and Building to Shenzhen City Government	08/04	MT
Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024	28/03	CI
Olympus Corporation Announces the Impact of the 2024 Noto Peninsula Earthquake	28/03	CI
Olympus Corporation Announces the Retirement of the Directors	28/03	CI
Olympus Corp. Completes 80 Billion Yen Buyback Program; Will Cancel 3% of Shares Effective April 30	27/03	MT
Tranche Update on Olympus Corporation's Equity Buyback Plan announced on November 9, 2023.	26/03	CI
Olympus Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024	26/03	CI
Olympus Corporation's Equity Buyback announced on November 9, 2023, has closed with 37,446,500 shares, representing 3.11% for ¥79,999.78 million.	22/03	CI
Olympus Backpedals on Taewoong Medical Acquisition	11/03	MT
Olympus Corporation Revises Consolidated Revenue Guidance for the Fiscal Year Ending March 31, 2024	01/03	CI
Grifols appoints new CEO Nacho Abia to the board	27/02	RE

Chart Olympus Corporation

Duration

Period

More charts

Company Profile

Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows: - medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.; - medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology; - scientific analysis instruments and microscopes (13.7%); - other (1.5%): biomedical materials, orthopedic equipment, etc. Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

07/08/2024 - Q1 2024 Earnings Release

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Olympus Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,682 JPY

Average target price

2,774 JPY

Spread / Average Target

+3.40%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OLYMPUS CORPORATION	+31.46%	19.28B
THERMO FISHER SCIENTIFIC	+4.64%	212B
DANAHER CORPORATION	+9.03%	187B
INTUITIVE SURGICAL, INC.	+28.07%	155B
BOSTON SCIENTIFIC CORPORATION	+34.17%	115B
SIEMENS HEALTHINEERS AG	+2.17%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+14.54%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	45.25B
AGILENT TECHNOLOGIES, INC.	-3.47%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.52%	37.72B

Other Advanced Medical Equipment & Technology